Pharmacologic Drug Detection and Self-Reported Adherence in the HPTN069/ACTG5305 Phase II PrEP Trial.

Saved in:
Bibliographic Details
Title: Pharmacologic Drug Detection and Self-Reported Adherence in the HPTN069/ACTG5305 Phase II PrEP Trial.
Authors: Cooper SE; Division of Infectious Diseases, Weill Cornell Medicine, 525 East 68th Street, Baker 24, New York, NY, 10065, USA. sec9059@med.cornell.edu., Zhang S; Fred Hutchison Cancer Center, Seattle, WA, USA., Haines D; Fred Hutchison Cancer Center, Seattle, WA, USA., Mayer KH; Fenway Health, Harvard Medical School, Boston, MA, USA., Amico KR; University of Michigan, Ann Arbor, MI, USA., Landovitz RJ; University of California, Los Angeles, CA, USA., Hendrix CW; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Marzinke MA; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Chege W; DAIDS, NIAID, NIH, Bethesda, MD, USA., McCauley M; Durham, NC, FHI 360, USA., Gulick RM; Division of Infectious Diseases, Weill Cornell Medicine, 525 East 68th Street, Baker 24, New York, NY, 10065, USA.
Source: AIDS and behavior [AIDS Behav] 2024 Nov; Vol. 28 (11), pp. 3710-3718. Date of Electronic Publication: 2024 Jul 31.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II
Journal Info: Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 9712133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-3254 (Electronic) Linking ISSN: 10907165 NLM ISO Abbreviation: AIDS Behav Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1573-3254
DOI:10.1007/s10461-024-04451-7